ACOG
Alpha Cognition Inc
Biotechnology
Alpha Cognition Inc (ACOG) Stock News
The latest ACOG headlines and market coverage — 1 recent story, updated throughout the day.
- The Motley Fool·
Alpha Cognition (ACOG) Q1 2026 Earnings Transcript
Alpha Cognition reported Q1 2026 revenue of $3.5 million, up 40% sequentially, driven by ZUNVEYL Alzheimer's drug sales. The company expanded its prescriber base to 1,060 healthcare professionals (23% growth) and nursing home penetration to 914 facilities (25% growth). With a fully staffed 60-person sales team and three ongoing clinical studies, ACOG reaffirmed its 2026 operating expense guidance of $54-58 million and remains on track for operating profitability in 2027. The company maintains a debt-free balance sheet with $54.2 million in cash.